PT-141 serves as a cutting-edge cyclic melanocortin agonist that possesses potential in the treatment of sexual dysfunction. This novel compound functions by stimulating specific receptors within the body, causing to augmented sexual function. Clinical studies have indicated that PT-141 could significantly address a spectrum of sexual dysfunctions